A new guidepaper from InformedDNA aims to help health plans reduce some high costs associated with genetic testing.
InformedDNA says overbilling and subsequent overpayment for genetic testing are key areas where there are “inappropriate genetic testing” expenses.
The following are some ways in which payers can both identify and reduce unnecessary claims payments:
- Building automated claims edits and payment rules into your claims processing system;
- Conducting analyses of genetic testing claims trends; and
- Using the results of claims analyses to strengthen lab contract negotiations.